White, B., Showers, K., Menendez, C. S., Amacker-North, L., Carpenter, K. W., Lenarcic, S., … White, R. L. (2015). Genetic testing for hereditary breast cancer: The decision to decline. In Journal of Clinical Oncology (Vol. 33, pp. 1552–1552). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.1552

White, Brook, Kimberly Showers, Carolyn S. Menendez, Lisa Amacker-North, Kendall W. Carpenter, Stacy Lenarcic, Lindsay McNeely, Claire Harwood, Beth Dellinger, and Richard L. White. “Genetic testing for hereditary breast cancer: The decision to decline.” In Journal of Clinical Oncology, 33:1552–1552. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.1552.

White B, Showers K, Menendez CS, Amacker-North L, Carpenter KW, Lenarcic S, et al. Genetic testing for hereditary breast cancer: The decision to decline. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 1552–1552.

White, Brook, et al. “Genetic testing for hereditary breast cancer: The decision to decline.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 1552–1552. Crossref, doi:10.1200/jco.2015.33.15_suppl.1552.

White B, Showers K, Menendez CS, Amacker-North L, Carpenter KW, Lenarcic S, McNeely L, Harwood C, Dellinger B, White RL. Genetic testing for hereditary breast cancer: The decision to decline. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 1552–1552.